Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on UK Healthcare Gazette.
Press releases published on August 18, 2025

Today the World Unites to Celebrate Never Give Up Day
From personal struggles to global challenges, August 18 unites the world in honoring resilience, courage, and the unstoppable spirit to never give up LONDON, UNITED KINGDOM, August 18, 2025 /EINPresswire.com/ -- Today, millions of people across the …

Millions Worldwide Celebrate Never Give Up Day
LONDON, UNITED KINGDOM, August 18, 2025 /EINPresswire.com/ -- Across cities, countries, and continents, millions unite today to celebrate Never Give Up Day, a global movement honoring resilience, perseverance, and the human spirit’s unshakable …

Swine Feed Minerals Global Market Report 2025| Business Growth, Development Factors, Current and Future Trends till 2029
The Business Research Company’s Swine Feed Minerals Global Market Report 2025 - Market Size, Trends, And Global Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, August 18, 2025 /EINPresswire.com/ -- Get 30% Off All Global Market Reports With …

Demand for Flea, Tick, And Heartworm Products Market is forecasted to reach a value of US $5.44 billion by 2029
The Business Research Company’s Demand for Flea, Tick, And Heartworm Products Global Market Report 2025 - Market Size, Trends, And Global Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, August 18, 2025 /EINPresswire.com/ -- Get 30% Off All …

Poultry Healthcare Market to Reach $13.55 Billion by 2029 with 9.9% CAGR
The Business Research Company’s Poultry Healthcare Global Market Report 2025 - Market Size, Trends, And Global Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, August 18, 2025 /EINPresswire.com/ -- Get 30% Off All Global Market Reports With …

Biodexa Announces Enrolment of First Patients into Pivotal Phase 3 Serenta Trial in Familial Adenomatous Polyposis (FAP)
August 18, 2025 Biodexa Announces Enrolment of First Patients into Pivotal Phase 3 Serenta Trial in Familial Adenomatous Polyposis (FAP) Opportunity to be First Mover in $7.3Bn Addressable Market Biodexa Pharmaceuticals PLC (“Biodexa” or “the Company”), ( …